13F filer · CIK 1697748 ↗
ARK Invest
You are looking at Q3 2020. See the latest, Q2 2026 →
Reported value
$16.86B
+81% on the quarter before
Positions
223
28 new · 18 sold out
Top 10
43.2%
of the value
Est. gain
+$1.21B
on stocks held all quarter
Est. return
+14.0%
on those stocks since Q2 2020
Positions as of Sep 30, 2020, from ARK Invest's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q2 2020. Striped tiles are options.
Largest buys
Since Q2 2020, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Tesla~$1.17BAdded · 8.3% → 8.7%+2,718,430 shares
- Zillow Group Inc~$497.9MNew · 0.0% → 3.0%+4,901,109 shares
- Teladoc Health Inc~$412.2MAdded · 0.3% → 2.6%+1,880,057 shares
- Slack Technologies Inc~$250.2MAdded · 1.6% → 2.2%+9,316,364 shares
- Everpure~$222.9MAdded · 2.1% → 2.3%+14,480,352 shares
- TSMC~$203.8MAdded · 0.1% → 1.3%+2,513,677 shares
- Twilio~$182.4MAdded · 0.3% → 1.3%+738,212 shares
- Spotify Technology Sa~$174.4MAdded · 1.1% → 1.6%+718,914 shares
- Invitae Corp~$170.5MAdded · 7.8% → 7.1%+3,934,027 shares
- Crispr Therapeutics Ag~$165.1MAdded · 5.1% → 4.2%+1,974,069 shares
Largest sells
Since Q2 2020, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Zillow Group Inc~$289.3MSold out · 3.1% → 0.0%−5,033,059 shares
- Teradyne~$114.9MCut · 1.6% → 0.1%−1,445,697 shares
- Autodesk~$65.8MCut · 0.9% → 0.1%−284,680 shares
- Pinterest Inc~$63.2MCut · 1.8% → 1.5%−1,522,692 shares
- Block~$33.5MCut · 6.8% → 5.6%−205,854 shares
- Xilinx Inc~$25.1MCut · 2.2% → 1.1%−241,218 shares
- Guardant Health Inc~$25.1MCut · 0.4% → 0.2%−224,531 shares
- Inovio Pharmaceuticals Inc~$20.8MSold out · 0.2% → 0.0%−771,427 shares
- Alteryx Inc~$17.7MSold out · 0.2% → 0.0%−108,037 shares
- Organovo Holdings Inc~$14.9MSold out · 0.2% → 0.0%−27,138,427 shares
Holdings
As of Sep 30, 2020. Changes are in shares against Jun 30, 2020, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TeslaCommon Stock · shares +382% · price −60.3% | 8.7% | $1.47B | −$463.6M | ||||||||
| Invitae CorpCommon Stock · shares +17% · price +43.1% | 7.1% | $1.20B | +$311.1M | ||||||||
| BlockCommon Stock · shares −3.4% · price +54.9% | 5.6% | $947.7M | +$335.9M | ||||||||
| Roku IncCommon Stock · shares +19% · price +62.0% | 4.4% | $746.6M | +$240.2M | ||||||||
| Crispr Therapeutics AgCommon Stock · shares +30% · price +13.8% | 4.2% | $707.4M | +$65.8M | ||||||||
| Zillow Group IncCommon Stock · shares New | 3.0% | $497.9M | — | ||||||||
| 2u IncCommon Stock · shares +38% · price −10.8% | 2.7% | $448.3M | −$39.5M | ||||||||
| Teladoc Health IncCommon Stock · shares +1,416% · price +14.9% | 2.6% | $441.3M | +$3.8M | ||||||||
| Lendingtree IncCommon Stock · shares +43% · price +6.0% | 2.5% | $413.7M | +$16.3M | ||||||||
| Proto Labs IncCommon Stock · shares +40% · price +15.1% | 2.4% | $400.7M | +$37.7M | ||||||||
| EverpureCommon Stock · shares +130% · price −11.2% | 2.3% | $393.9M | −$21.6M | ||||||||
| Slack Technologies IncCommon Stock · shares +197% · price −13.6% | 2.2% | $377.2M | −$20.0M | ||||||||
| Seres Therapeutics IncCommon Stock · shares −1.5% · price +494.7% | 2.1% | $348.0M | +$289.5M | ||||||||
| Illumina IncCommon Stock · shares +5.4% · price −16.5% | 1.8% | $302.5M | −$56.9M | ||||||||
| Editas Medicine IncCommon Stock · shares +41% · price −5.1% | 1.8% | $299.4M | −$11.5M | ||||||||
| Pagerduty IncCommon Stock · shares +104% · price −5.3% | 1.7% | $287.9M | −$7.8M | ||||||||
| Compugen LtdCommon Stock · shares +25% · price +8.2% | 1.7% | $287.2M | +$17.3M | ||||||||
| Spotify Technology SaCommon Stock · shares +177% · price −6.0% | 1.6% | $272.7M | −$6.3M | ||||||||
| Iovance Biotherapeutics IncCommon Stock · shares +87% · price +19.9% | 1.5% | $260.2M | +$23.2M | ||||||||
| Pinterest IncCommon Stock · shares −20% · price +87.2% | 1.5% | $250.7M | +$116.8M | ||||||||
| Twist Bioscience CorpCommon Stock · shares +92% · price +67.7% | 1.4% | $240.1M | +$50.4M | ||||||||
| Splunk IncCommon Stock · shares +30% · price −5.3% | 1.4% | $239.2M | −$10.4M | ||||||||
| Materialise NvADR · shares +33% · price +63.6% | 1.4% | $233.3M | +$68.3M | ||||||||
| Veracyte IncCommon Stock · shares +39% · price +25.4% | 1.4% | $228.0M | +$33.4M | ||||||||
| Intellia Therapeutics IncCommon Stock · shares +0.01% · price −5.4% | 1.3% | $226.7M | −$13.0M | ||||||||
| Total · 223 positions | 100% | $16.86B | +$1.21B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2020 to Q3 2020: 195 stocks held throughout, up $1.21B (+14.0%).
- Block+$335.9M+55%
- Invitae Corp+$311.1M+43%
- Seres Therapeutics Inc+$289.5M+495%
- Roku Inc+$240.2M+62%
- Pinterest Inc+$116.8M+87%
- Apple−$25.8M−68%
- Stratasys Ltd−$38.3M−21%
- 2u Inc−$39.5M−11%
- Illumina Inc−$56.9M−17%
- Tesla−$463.6M−60%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $15.40B+20% | SEC ↗ |
| Q1 2026 | May 12, 2026 | $12.86B−15% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $15.07B−10% | SEC ↗ |
| Q3 2025 | Nov 12, 2025 | $16.80B+23% | SEC ↗ |
| Q2 2025 | Jul 30, 2025 | $13.64B+37% | SEC ↗ |
| Q1 2025 | May 7, 2025 | $9.99B−17% | SEC ↗ |
| Q4 2024 | Feb 4, 2025 | $12.01B+10% | SEC ↗ |
| Q3 2024 | Oct 31, 2024 | $10.93B−3% | SEC ↗ |
| Q2 2024 | Jul 26, 2024 | $11.27B−22% | SEC ↗ |
| Q1 2024 | Apr 18, 2024 | $14.44B−14% | SEC ↗ |
| Q4 2023 | Jan 17, 2024 | $16.89B+29% | SEC ↗ |
| Q3 2023 | Oct 18, 2023 | $13.07B−13% | SEC ↗ |
| Q2 2023 | Jul 10, 2023 | $15.10B+4% | SEC ↗ |
| Q1 2023 | Apr 17, 2023 | $14.55B+26% | SEC ↗ |
| Q4 2022 | Jan 24, 2023 | $11.54B−20% | SEC ↗ |
| Q3 2022 | Oct 17, 2022 | $14.35B−15% | SEC ↗ |
| Q2 2022 | Jul 11, 2022 | $16.91B−29% | SEC ↗ |
| Q1 2022 | Apr 18, 2022 | $23.96B−28% | SEC ↗ |
| Q4 2021 | Jan 28, 2022 | $33.08B−21% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $41.64B−23% | SEC ↗ |
| Q2 2021 | Aug 5, 2021 | $53.74B+7% | SEC ↗ |
| Q1 2021 | May 13, 2021 | $50.34B+34% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $37.59B+123% | SEC ↗ |
| Q3 2020 | Oct 30, 2020 | $16.86B+81% | SEC ↗ |
| Q2 2020 | Aug 11, 2020 | $9.30B+132% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $4.01B+1% | SEC ↗ |
| Q4 2019 | Jan 31, 2020 | $3.96B−13% | SEC ↗ |
| Q3 2019 | Nov 12, 2019 | $4.58B+15% | SEC ↗ |
| Q2 2019 | Jul 30, 2019 | $3.97B+13% | SEC ↗ |
| Q1 2019 | May 13, 2019 | $3.50B+42% | SEC ↗ |
| Q4 2018 | Feb 11, 2019 (amended) | $2.46B−26% | SEC ↗ |
| Q3 2018 | Nov 7, 2018 | $3.31B+21% | SEC ↗ |
| Q2 2018 | Aug 7, 2018 | $2.73B+36% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $2.01B+60% | SEC ↗ |
| Q4 2017 | Feb 12, 2018 | $1.26B+53% | SEC ↗ |
| Q3 2017 | Nov 9, 2017 | $819.3M+60% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $513.6M+48% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $346.9M+26% | SEC ↗ |
| Q4 2016 | Feb 13, 2017 | $274.9M | SEC ↗ |